187 related articles for article (PubMed ID: 17852716)
41. Candida glabrata endophthalmitis treated successfully with caspofungin.
Sarria JC; Bradley JC; Habash R; Mitchell KT; Kimbrough RC; Vidal AM
Clin Infect Dis; 2005 Mar; 40(5):e46-8. PubMed ID: 15714407
[TBL] [Abstract][Full Text] [Related]
42. A case of Candida krusei peritonitis secondary to duodenal perforation due to Candida duodenitis.
Cascio A; Bartolotta M; Venneri A; Musolino C; Iaria C; Delfino D; Navarra G
Mycopathologia; 2011 Jan; 171(1):51-5. PubMed ID: 20632210
[TBL] [Abstract][Full Text] [Related]
43. Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin.
Alanio A; Brethon B; Feuilhade de Chauvin M; de Kerviler E; Leblanc T; Lacroix C; Baruchel A; Menotti J
Clin Infect Dis; 2008 May; 46(10):e116-8. PubMed ID: 18419477
[TBL] [Abstract][Full Text] [Related]
44. [Successful caspofungin treatment of invasive refractory candidiasis in the extremely low birthweight neonate].
Lopes A; Rocha G; Vilan A; Guedes MB; Guimarães H
Acta Med Port; 2010; 23(4):719-22. PubMed ID: 20688004
[TBL] [Abstract][Full Text] [Related]
45. Caspofungin for the treatment of azole resistant candidemia in a premature infant.
Smith PB; Steinbach WJ; Cotten CM; Schell WA; Perfect JR; Walsh TJ; Benjamin DK
J Perinatol; 2007 Feb; 27(2):127-9. PubMed ID: 17262048
[TBL] [Abstract][Full Text] [Related]
46. Candida glabrata spinal osteomyelitis.
Dailey NJ; Young EJ
Am J Med Sci; 2011 Jan; 341(1):78-82. PubMed ID: 21030857
[TBL] [Abstract][Full Text] [Related]
47. Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation.
Girmenia C; Moleti ML; Micozzi A; Iori AP; Barberi W; Foà R; Martino P
J Clin Microbiol; 2005 Oct; 43(10):5395-6. PubMed ID: 16208029
[TBL] [Abstract][Full Text] [Related]
48. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
Espinel-Ingroff A
Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
[TBL] [Abstract][Full Text] [Related]
49. The echinocandins.
Cappelletty D; Eiselstein-McKitrick K
Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149
[TBL] [Abstract][Full Text] [Related]
50. Efficacy of caspofungin in invasive candidiasis and candidemia--de-escalation strategy.
Lichtenstern C; Nguyen TH; Schemmer P; Hoppe-Tichy T; Weigand MA
Mycoses; 2008; 51 Suppl 1():35-46. PubMed ID: 18471160
[TBL] [Abstract][Full Text] [Related]
51. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
Agarwal MB; Rathi SA; Ratho N; Subramanian R
J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012
[TBL] [Abstract][Full Text] [Related]
52. Caspofungin in the treatment of oropharyngeal candidiasis.
Garbino J; Lew D; Hirschel B; Rohner P
Int J Clin Pract; 2003 Mar; 57(2):143-4. PubMed ID: 12661800
[TBL] [Abstract][Full Text] [Related]
53. An unusual cause of vertebral osteomyelitis: Candida species.
Garbino J; Schnyder I; Lew D; Bouchuiguir-Wafa K; Rohner P
Scand J Infect Dis; 2003; 35(4):288-91. PubMed ID: 12839165
[TBL] [Abstract][Full Text] [Related]
54. Caspofungin in combination with amphotericin B against Candida glabrata.
Barchiesi F; Spreghini E; Fothergill AW; Arzeni D; Greganti G; Giannini D; Rinaldi MG; Scalise G
Antimicrob Agents Chemother; 2005 Jun; 49(6):2546-9. PubMed ID: 15917570
[TBL] [Abstract][Full Text] [Related]
55. Antifungal activity of voriconazole (UK-109,496), fluconazole and amphotericin B against hematogenous Candida krusei infection in neutropenic guinea pig model.
Ghannoum MA; Okogbule-Wonodi I; Bhat N; Sanati H
J Chemother; 1999 Feb; 11(1):34-9. PubMed ID: 10078778
[TBL] [Abstract][Full Text] [Related]
56. Candida krusei arthritis in an adolescent with acute myelogenous leukemia.
Larru B; Barrett DM; Gerber JS
Pediatr Infect Dis J; 2013 Oct; 32(10):1142-4. PubMed ID: 23563520
[TBL] [Abstract][Full Text] [Related]
57. Treatment of a critically ill child with disseminated Candida glabrata with a recombinant human antibody specific for fungal heat shock protein 90 and liposomal amphotericin B, caspofungin, and voriconazole.
Sutherland A; Ellis D
Pediatr Crit Care Med; 2008 Jul; 9(4):e23-5. PubMed ID: 18843247
[TBL] [Abstract][Full Text] [Related]
58. Candida tropicalis arthritis of the knee in a patient with acute lymphoblastic leukaemia: successful treatment with caspofungin.
Sim JP; Kho BC; Liu HS; Yung R; Chan JC
Hong Kong Med J; 2005 Apr; 11(2):120-3. PubMed ID: 15815067
[TBL] [Abstract][Full Text] [Related]
59. Misidentification of Candida parapsilosis as C famata in a clinical case of vertebral osteomyelitis.
Burton MJ; Shah P; Swiatlo E
Am J Med Sci; 2011 Jan; 341(1):71-3. PubMed ID: 20944497
[TBL] [Abstract][Full Text] [Related]
60. Second-line therapy with caspofungin for mucosal or invasive candidiasis: results from the caspofungin compassionate-use study.
Kartsonis NA; Saah A; Lipka CJ; Taylor A; Sable CA
J Antimicrob Chemother; 2004 May; 53(5):878-81. PubMed ID: 15044431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
